ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

LXRX Lexicon Pharmaceuticals Inc

1.66
0.01 (0.61%)
最終更新日: 00:17:04
15分遅延
名称 銘柄コード 市場 種別
Lexicon Pharmaceuticals Inc LXRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.61% 1.66 00:17:04
始値 安値 高値 終値 前日終値
1.73 1.65 1.75 1.65
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2922:00GLOBELonnel Coats Retires as Chief Executive Officer and Board..
2024/4/2920:00GLOBELexicon Pharmaceuticals to Host First Quarter 2024 Financial..
2024/4/1821:00GLOBELexicon Pharmaceuticals to Host 2024 Investor Day
2024/4/0321:00GLOBELexicon Pharmaceuticals to Participate in the 23rd Annual..
2024/3/2522:20GLOBEClinical Data on the Impact of Sotagliflozin on Stroke and..
2024/3/1221:00GLOBENew Post Hoc Analysis of inTandem3 Study Demonstrates..
2024/3/1205:25EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/3/1120:26EDGAR2Form 8-K - Current report
2024/3/1120:15GLOBELexicon Pharmaceuticals Reports Fourth Quarter..
2024/3/1120:05GLOBELexicon Announces Oversubscribed $250 Million Private..
2024/3/1120:00GLOBELexicon Preparing to Resubmit Sotagliflozin NDA for Type 1..
2024/3/0106:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0821:00GLOBELexicon Pharmaceuticals Provides Business and Pipeline..
2023/12/3007:29EDGAR2Form 8-K - Current report
2023/12/3007:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/3006:04EDGAR2Form 8-K - Current report
2023/12/2206:15GLOBELexicon Pharmaceuticals To Participate In The 42nd Annual..
2023/11/3021:30GLOBELexicon Enrolls First Patient in Phase 2b Progress Study of..
2023/11/2221:30GLOBELexicon Pharmaceuticals to Participate in the 35th Annual..
2023/11/1806:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1304:10GLOBEINPEFA® (sotagliflozin) Use Associated With Early Clinical..
2023/11/1106:01GLOBELexicon Pharmaceuticals to Participate in the Jefferies..
2023/11/0906:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0821:22EDGAR2Form 8-K - Current report
2023/11/0821:00GLOBELexicon Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/0322:00GLOBELexicon Pharmaceuticals to Host Third Quarter 2023 Financial..
2023/11/0222:00GLOBEData on Early Clinical Benefit for INPEFA® (Sotagliflozin)..
2023/11/0122:00GLOBEINPEFA® (Sotagliflozin) Receives Coverage From Express..
2023/11/0105:01GLOBELexicon Strengthens Management Team With Two New Executives
2023/10/3105:01GLOBENew Data Relating to Sotagliflozin to be Presented at the..
2023/10/1805:01GLOBEData From Two Studies Demonstrating Positive Financial..
2023/10/1205:06EDGAR2Form 8-K - Current report
2023/10/1205:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1205:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/1122:00GLOBEData Demonstrating Financial Impact of INPEFA®..
2023/10/1005:01GLOBEINPEFA® (Sotagliflozin) Receives Preferred Formulary Status..
2023/10/0921:00GLOBETom Garner Joins Lexicon as Senior Vice President and Chief..
2023/9/2822:00GLOBELexicon to Present Post Hoc Analysis of Scored Clinical..
2023/9/2622:00GLOBELexicon to Present Study Results Relating to Sotagliflozin..

最近閲覧した銘柄

Delayed Upgrade Clock